Behavioral and neurochemical alterations following repeated phencyclidine administration in rats with neonatal ventral hippocampal lesions

Neuropharmacology

Volumn 39, Issue 12, 2000, Pages 2478-2491

  Hori, Takafumi ^a   Subramaniam, Sabarinath ^a   Srivastava, Lalit K ^a   Quirion, Rémi ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Forced swimming test; Locomotor activity; Neonatal ventral hippocampal lesion; Neurodevelopment; Phencyclidine; Schizophrenia

Indexed keywords

DOPAMINE 1 RECEPTOR; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INJURY; CAUDATE NUCLEUS; CONTROLLED STUDY; FEMALE; FORCED SWIMMING TEST; HIPPOCAMPUS; LOCOMOTION; NERVE CELL DIFFERENTIATION; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PUTAMEN; RECEPTOR DENSITY; SCHIZOPHRENIA;

ANIMALS; ANIMALS, NEWBORN; AUTORADIOGRAPHY; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; DEPRESSION; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HIPPOCAMPUS; MOTOR ACTIVITY; PHENCYCLIDINE; RATS; RATS, INBRED F344; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, N-METHYL-D-ASPARTATE; STEREOTYPED BEHAVIOR; SWIMMING;

EID: 0033876429     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(00)00059-9     Document Type: Article

References (69)

1. Al-Amin H.A., Lipska B.K., Lillrank S.M., Phillips I., Weinberger D.R. Postpubertal modulation of NMDA system after neonatal ventral hippocampus (VH) lesions in rats. Society of Neuroscience Abstracts. 23:1997;1363.
2. Ambrogi Lorenzini C.G., Baldi E., Bucherelli C., Sacchetti B., Tassoni G. Role of ventral hippocampus in acquisition, consolidation and retrieval of rat's passive avoidance response memory trace. Brain Research. 768:1997;242-248.
3. Barnes T.R.E., Curson D.A., Liddle P.F., Patel M. The nature and prevalence of depression in chronic schizophrenic in-patients. British Journal of Psychiatry. 154:1989;486-491.
4. Brake W.G., Sullivan R.M., Flores G., Srivastava L.K., Gratton A. Neonatal ventral hippocampal lesions attenuate the nucleus accumbens dopamine response to stress: an electrochemical study in the adult rat. Brain Research. 831:1999;25-32.
5. Brozoski T.J., Brown R.M., Rosvold H.E., Goldman P.S. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science. 205:1979;929-932.
6. Bunney B.G., Bunney W.E. Jr., Carlsson A. Schizophrenia and glutamate. Bloom F.E., Kupfer D.J. Psychopharmacology: The Fourth Generation of Progress. 1995;1205-1214 Raven Press, New York.
7. Carlsson M., Carlsson A. Schizophrenia: a subcortical neurotransmitter imbalance syndrome? Schizophrenia Bulletin. 16:1990;425-432.
8. Chambers R.A., Moore J., McEvoy J.P., Levin E.D. Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia. Neuropsychopharmacology. 15:1996;587-594.
9. Clow D.W., Jhamandas K. Characterization of L-glutamate action on the release of endogenous dopamine from the rat caudate-putamen. Journal of Pharmacology, Experiment and Therapeutics. 248:1989;722-728.
10. Daniel D.G., Weinberger D.R., Jones D.W., Zigun J.R., Coppola R., Handel S., Bigelow L.B., Goldberg T.E., Berman K.F., Kleinman J.E. The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. Journal of Neuroscience. 11:1991;1907-1917.
11. De Pablo J.M., Parra A., Segovia S., Guillanón A. Learned immobility explains the behavior of rats in the forced swim test. Physiology and Behaviour. 46:1989;229-237.
12. Deutch A.Y., Tam S.-Y., Freeman A.S., Bowers M.B. Jr., Roth R.H. Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response. European Journal of Pharmacology. 134:1987;257-264.
13. Espejo E.F., Miñano F.J. Prefrontocortical dopamine depletion induces antidepressant-like effects in rats and alters the profile of desipramine during Porsolt's test. Neuroscience. 88:1999;609-615.
14. Flores G., Barbeau D., Quirion R., Srivastava L.K. Decreased binding of dopamine D3 receptors in limbic subregions after neonatal bilateral lesion of rat hippocampus. Journal of Neuroscience. 16:1996;2020-2026.
15. Flores G., Wood G.K., Liang J.-J., Quirion R., Srivastava L.K. Enhanced amphetamine sensitivity and increased expression of dopamine D2 receptors in postpubertal rats after neonatal excitotoxic lesions of the medial prefrontal cortex. Journal of Neuroscience. 16:1996;7366-7375.
16. Freeman A.S., Bunney B.S. The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity. European Journal of Pharmacology. 104:1984;287-293.
17. 10 dopamine neurons in the rat. Neuropharmacology. 25:1986;241-248.
18. Garcia-Marquez C., Armario A. Chronic stress depresses exploratory activity and behavioral performance in the forced swimming test without altering ACTH response to a novel acute stressor. Physiology and Behaviour. 40:1987;33-38.
19. Geyer M.A., Segal D.S., Greenberg B.D. Increased startle responding in rats treated with phencyclidine. Neurobehaviour Toxicology and Teratology. 6:1984;161-164.
20. Godukhin O.V., Zharikova A.D., Novoselov V.I. The release of labeled L-glutamic acid from rat neostriatum in vivo following stimulation of frontal cortex. Neuroscience. 5:1980;2151-2154.
21. Grace A.A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience. 41:1991;1-24.
22. Greenberg B.D., Segal D.S. Acute and chronic behavioral interactions between phencyclidine (PCP) and amphetamine: evidence for a dopaminergic role in some PCP-induced behaviors. Pharmacology Biochemistry and Behaviour. 23:1985;99-105.
23. Healy D.J., Meador-Woodruff J.H. Differential regulation, by MK-801, of dopamine receptor gene expression in rat nigrostriatal and mesocorticolimbic systems. Brain Research. 708:1996;38-44.
24. Herve D., Trovero F., Blanc G., Thierry A.M., Glowinski J., Tassin J.P. Nondopaminergic prefrontocortical efferent fibers modulate D1 receptor denervation supersensitivity in specific regions of the rat striatum. Journal of Neuroscience. 9:1989;3699-3708.
25. Hondo H., Yonezawa Y., Nakahata T., Nakamura K., Hirano M., Uchimura H., Tashiro N. Effect of phencyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study. Brain Research. 633:1994;337-342.
26. Jarrard L.E. On the role of the hippocampus in learning and memory in the rat. Behaviour and Neural Biology. 60:1993;9-26.
27. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. American Journal of Psychiatry. 148:1991;1301-1308.
28. Jay T.M., Burette F., Laroche S. Plasticity of the hippocampal-prefrontal cortex synapses. Journal of Physiology (Paris). 90:1996;361-366.
29. 5]Enkephalinamide. European Journal of Pharmacology. 92:1983;99-103.
30. Jentsch J.D., Tran A., Le D., Youngren K.D., Roth R.H. Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology. 17:1997;92-99.
31. Jentsch J.D., Taylor J.R., Roth R.H. Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion. Neuropsychopharmacology. 19:1998;105-113.
32. Jentsch J.D., Roth R.H. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology. 20:1999;201-225.
33. Le Jeune H., Cécyre D., Rowe W., Meaney M.J., Quirion R. Ionotropic glutamate. Receptor subtypes in the aged memory-impaired and unimpaired Long-Evans rat. Neuroscience. 74:1996;349-363.
34. Lipska B.K., Jaskiw G.E., Weinberger D.R. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology. 9:1993;67-75.
35. Lipska B.K., Swerdlow N.R., Geyer M.A., Jaskiw G.E., Braff D.L., Weinberger D.R. Neonatal excitotoxic hippocampal damage in rats causes postpubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology. 122:1995;35-43.
36. Lipska B.K., Chrapusta S.J., Egan M.F., Weinberger D.R. Neonatal exitotoxic ventral hippocampal damage alters dopamine response to mild repeated stress and to chronic haloperidol. Synapse. 20:1995;125-130.
37. Lipton A.A., Cancro R. Schizophrenia: clinical features. Kaplan H.I., Sadock B.J. Comprehensive Textbook of Psychiatry. 6th ed:1995;968-987 Williams and Wilkins, Baltimore.
38. 3H]D-AP5, suggesting down-regulation of the cortical N-methyl-D-aspartate receptors. Neuroscience. 30:1989;87-94.
39. Martin J.R., Berman M.H., Krewsun I., Small S.F. Phencyclidine-induced stereotyped behavior and serotonergic syndrome in rat. Life Science. 24:1979;1699-1704.
40. McGeorge A.J., Faull R.L.M. The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience. 29:1989;503-537.
41. Nabeshima T., Yamaguchi K., Yamada K., Hiramatsu M., Furukawa H., Kameyama T. Phencyclidine-induced stereotyped behaviors in rats following specific neurotoxin lesions of the striatum. European Journal of Pharmacology. 93:1983;229-234.
42. Nabeshima T., Fukaya H., Yamaguchi K., Ishikawa K., Furukawa H., Kameyama T. Development of tolerance and supersensitivity to phencyclidine in rats after repeated administration of phencyclidine. European Journal of Pharmacology. 135:1987;23-33.
43. Noda Y., Yamada K., Furukawa H., Nabeshima T. Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia. British Journal of Pharmacology. 116:1995;2531-2537.
44. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed:1986;Academic Press, New York.
45. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature. 266:1977;730-732.
46. 2 dopamine receptor messenger RNA is altered to a greater extent by blockade of glutamate receptors than by blockade of dopamine receptors. Neuroscience. 60:1994;97-114.
47. Quirion R., Bayorh M.A., Zerbe R.L., Pert C.B. Chronic phencyclidine treatment decreases phencyclidine and dopamine receptors in rat brain. Pharmacology Biochemistry and Behaviour. 17:1982;699-702.
48. 3H]spiroperidol binding in rat striatum. European Journal of Pharmacology. 78:1982;363-365.
49. Sams-Dodd F. Automation of the social interaction task by a video-tracking system: behavioural effects of repeated phencyclidine treatment. Journal of Neuroscience Methods. 59:1995;157-167.
50. Sams-Dodd F., Lipska B.K., Weinberger D.R. Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood. Psychopharmacology. 132:1997;303-310.
51. Saransaari P., Lillrank S.M., Oja S.S. Phencyclidine treatment in mice: effects on phencyclidine binding sites and glutamate uptake in cerebral cortex preparations. Journal of Neural Transmission [GenSect]. 93:1993;47-59.
52. Sawaguchi T., Goldman-Rakic P.S. D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science. 251:1991;947-950.
53. Schroeder U., Ehrhardt J., Schroeder H., Sabel B.A. Can continuously applied phencyclidine stimulate psychosis-like behavior in rats? Society of Neuroscience Abstracts. 24:1998;1997.
54. 3H]serotonin uptake in synaptosomal preparations from rat brain. Biochemical Pharmacology. 26:1977;1435-1439.
55. Snell L.D., Mueller Z.L., Gannon R.L., Silverman P.B., Johnson K.M. A comparison between classes of drugs having phencyclidine-like behavioral properties on dopamine efflux in vitro and dopamine metabolism in vivo. Journal of Pharmacology, Experiment and Therapeutics. 231:1984;261-269.
56. Spain J.W., Klingman G.I. Continuous intravenous infusion of phencyclidine in unrestrained rats results in the rapid induction of tolerance and physical dependence. Journal of Pharmacology, Experiment and Therapeutics. 234:1985;415-424.
57. 3H]Spiperone binding in the rat striatum during the development of physical dependence on phencyclidine and after withdrawal. Neuroscience Letters. 58:1985;67-72.
58. Squire L.R. Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychology Review. 99:1992;195-231.
59. Steinpreis R.E., Sokolowski J.D., Papanikolaou A., Salamone J.D. The effects of haloperidol and clozapine on PCP- and amphetamine-induced suppression of social behavior in the rat. Pharmacology Biochemistry and Behaviour. 47:1994;579-585.
60. Sturgeon R.D., Fessler R.G., London S.F., Meltzer H.Y. Behavioral effects of chronic phencyclidine administration in rats. Psychopharmacology. 76:1982;52-56.
61. 2 and GluR-1 glutamate receptor mRNAs in the rat brain after treatment with phencyclidine. Acta Medica Okayama. 49:1995;61-68.
62. Veldhuis H.D., De Korte C.C.M.M., De Kloet E.R. Glucocorticoids facilitate the retention of acquired immobility during forced swimming. European Journal of Pharmacology. 115:1985;211-217.
63. Wan R.-Q., Giovanni A., Kafka S.H., Corbett R. Neonatal hippocampal lesions induced hyperresponsiveness to amphetamine: behavioral and in vivo microdialysis studies. Behaviour and Brain Research. 78:1996;211-223.
64. Wang J.T.K. Presynaptic glutamate receptors modulate dopamine release from striatal synaptosomes. Journal of Neurochemistry. 57:1991;819-822.
65. Wedzony K., Klimek V., Golembiowska K. MK-801 elevates the extracelllular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors. Brain Research. 622:1993;325-329.
66. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Archives in General Psychiatry. 44:1987;660-669.
67. Weinberger D.R., Berman K.F., Illowsky B.P. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia: a new cohort and evidence for a monoaminergic mechanism. Archives in General Psychiatry. 45:1988;609-615.
68. Weinberger D.R., Lipska B.K. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground. Schizophrenia Research. 16:1995;87-110.
69. West A.P. Neurobehavioral studies of forced swimming: the role of learning and memory in the forced swim test. Progress in Neuro-Psychopharmacology Biology and Psychiatry. 14:1990;863-877.